Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae (PASC) With Portable Brain Stimulation: a Double-blind, Randomized-controlled Trial

NCT05389592 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT05389592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae (PASC) With Portable Brain Stimulation: a Double-blind, Randomized-controlled Trial
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2022
Completion date
March 30, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, covid-19, post-acute sequelae of sars-cov-2 infection